R esults from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic ...

A study led by Dr Joseph J. Cullen from the University of Iowa reveals that high-dose intravenous vitamin C, when combined with chemotherapy, significantly increases the survival rate for patients ...

High-dose intravenous vitamin C combined with standard chemotherapy significantly extends survival in patients with metastatic pancreatic cancer. Learn more.

Research, including studies from the National Institutes of Health, suggests that intravenous Vitamin C can reduce pain within the first 24 hours post-surgery. Other vitamins, such as B-12 ...